Startups
We back bold entrepreneurs, champion their innovations, and work with them to build the future.
Our fund has a multi-stage focus, and is affiliated with iconic businesses in the retail, healthcare, real estate, and financial services verticals.
Our fund has a multi-stage focus, and is affiliated with iconic businesses in the retail, healthcare, real estate, and financial services verticals.
Overview
Location
Canada, Ontario, Toronto
Employees
1-10
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 21, 2026 | ViewsML Secures $4.9M for AI Biomarker Revolution | ViewsML secured $4.9M in seed funding. This fuels its AI-driven virtual biomarker platform. The technology extracts critical per-cell insights directly from standard H&E pathology images. It eliminates traditional immunohistochemistry. ... |
| Apr 21, 2026 | ViewsML Raises $4.9M for AI-Driven Virtual Biomarker Staining Platform | What You Should Know The Funding: ViewsML, a company building the computational layer for biomarker discovery, has closed an oversubscribed $4.9M seed round led by Wittington Ventures, with significant strategic participation from Mayo Clin... |
| Apr 20, 2026 | ViewsML Raises $4.9M in Seed Funding | ViewsML, a Vancouver, BC, Canada-based biomarker discovery company, raised $4.9M in seed funding. The round was led by Wittington Ventures with participation from Continuum Health Ventures, Mayo Clinic, RiSC Capital, Debiopharm, WUTIF, Defi... |
| Nov 19, 2025 | WellBeam Raises $10M Series A to Break EMR Silos Between Acute and Post-Acute Care | What You Should Know: – WellBeam, a healthcare technology company, announced that it has successfully raised $10M in Series A funding led by Wittington Ventures and included participation from F-Prime, Advocate Health, and Oncology Ventures... |
| Jul 30, 2024 | Truvian Health: Lab-Accurate Results Company Raises $74 Million | Truvian Health announced it is redefining the current global infrastructure through its novel platform, creating a world where central laboratory equivalent blood tests are available anywhere you go. Truvian raised $74 million in funding to... |
| Feb 25, 2024 | Abridge Revolutionizes Clinical Documentation with $150M Investment | Abridge, a trailblazer in generative AI for clinical documentation, has secured a massive $150 million Series C funding round led by Lightspeed Venture Partners. This funding, coming on the heels of a $30 million Series B round, solidifies ... |
| Feb 23, 2024 | Abridge Secures $150M to Expand GenAI, Partners with Yale New Haven Health System | What You Should Know: – Abridge, the leading force in generative AI for clinical documentation, announced today a staggering $150 million Series C funding round led by Lightspeed Venture Partners. The funding also includes participation fro... |
| Jan 5, 2023 | ODAIA Secures $25M for AI-Driven Commercial Insights Platform for Pharma | What You Should Know: ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, announced it raised an oversubscribed $25 Million Series B financing round, led by Threshold Ventures and co-l... |
| Aug 11, 2022 | Abridge Secures $12.5M to Power AI-Powered Medical Conversations | What You Should Know: Provider burnout continues to be a serious issue for healthcare systems, especially in the aftermath of the pandemic. National studies suggest that more than 50 percent of providers experience burnout-related symptoms,... |
Show more
Reviews 0
FAQ about Wittington Ventures
What has the press written about Wittington Ventures?
Parsers VC has collected 11 articles mentioning Wittington Ventures, among them “ViewsML Secures $4.9M for AI Biomarker Revolution” (Apr 21, 2026) and “ViewsML Raises $4.9M for AI-Driven Virtual Biomarker Staining Platform” (Apr 21, 2026).
Is Wittington Ventures still active?
Yes, Wittington Ventures is active; its latest activity on Parsers VC dates from Apr 23, 2026.